R. Darnell and J. Posner, Observing the invisible: successful tumor immunity in humans, Nature Immunology, vol.4, issue.3, p.201, 2003.
DOI : 10.1038/ni0303-201

R. Darnell and J. Posner, Paraneoplastic Syndromes Involving the Nervous System, New England Journal of Medicine, vol.349, issue.16, pp.1543-1554, 2003.
DOI : 10.1056/NEJMra023009

M. Albert, J. Darnell, A. Bender, L. Francisco, and N. Bhardwaj, Tumor-specific killer cells in paraneoplastic cerebellar degeneration, Nature Medicine, vol.182, issue.11, pp.1321-1324, 1998.
DOI : 10.1016/S0896-6273(00)80562-0

URL : https://hal.archives-ouvertes.fr/pasteur-01402438

M. Albert, L. Austin, and R. Darnell, Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration, Annals of Neurology, vol.21, issue.1, pp.9-17, 2000.
DOI : 10.1002/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I

URL : https://hal.archives-ouvertes.fr/pasteur-01402433

J. Banchereau and R. Steinman, Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998.
DOI : 10.1038/32588

L. Casciola-rosen, G. Anhalt, and A. Rosen, Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes, Journal of Experimental Medicine, vol.179, issue.4, pp.1317-1330, 1994.
DOI : 10.1084/jem.179.4.1317

R. Darnell, Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain., Proceedings of the National Academy of Sciences, vol.93, issue.10, pp.4529-4536, 1996.
DOI : 10.1073/pnas.93.10.4529

M. Albert, B. Sauter, and N. Bhardwaj, Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs, Nature, vol.392, issue.6671, pp.86-89, 1998.
DOI : 10.1038/32183

A. Palucka, H. Ueno, J. Fay, and J. Banchereau, Taming cancer by inducing immunity via dendritic cells, Immunological Reviews, vol.61, issue.1, pp.129-150, 2007.
DOI : 10.1016/j.cell.2006.01.007

G. Dunn, L. Old, and R. Schreiber, The Three Es of Cancer Immunoediting, Annual Review of Immunology, vol.22, issue.1, pp.329-360, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104803

K. Inaba, S. Turley, F. Yamaide, T. Iyoda, and K. Mahnke, Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells, The Journal of Experimental Medicine, vol.61, issue.11, pp.2163-2173, 1998.
DOI : 10.1016/0167-5699(92)90198-G

M. Li, G. Davey, R. Sutherland, C. Kurts, and A. Lew, Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo, The Journal of Immunology, vol.166, issue.10, pp.6099-6103, 2001.
DOI : 10.4049/jimmunol.166.10.6099

M. Albert, S. Pearce, L. Francisco, B. Sauter, and P. Roy, and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes, The Journal of Experimental Medicine, vol.265, issue.7, pp.1359-1368, 1998.
DOI : 10.1126/science.270.5241.1500

URL : https://hal.archives-ouvertes.fr/pasteur-01402441

N. Blachere, R. Darnell, and M. Albert, Apoptotic Cells Deliver Processed Antigen to Dendritic Cells for Cross-Presentation, PLoS Biology, vol.176, issue.6, p.185, 2005.
DOI : 10.1371/journal.pbio.0030185.sd001

URL : https://hal.archives-ouvertes.fr/inserm-00708471

M. Albert, M. Jegathesan, and R. Darnell, Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells, Nat Immunol, vol.9, pp.1-8, 2001.

F. Benencia and G. Coukos, Biological Therapy with Oncolytic Herpesvirus, Adv Exp Med Biol, vol.622, pp.221-233, 2008.
DOI : 10.1007/978-0-387-68969-2_18

H. Okada, I. Pollack, F. Lieberman, L. Lunsford, and D. Kondziolka, Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response, Hum Gene Ther, vol.12, pp.575-595, 2001.

S. Rutkowski, D. Vleeschouwer, S. Kaempgen, E. Wolff, J. Kuhl et al., Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study, British Journal of Cancer, vol.61, pp.1656-1662, 2004.
DOI : 10.1038/sj.bjc.6602195

C. Wheeler, K. Black, G. Liu, M. Mazer, and X. Zhang, Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients, Cancer Research, vol.68, issue.14, pp.5955-5964, 2008.
DOI : 10.1158/0008-5472.CAN-07-5973

R. Yamanaka, J. Homma, N. Yajima, N. Tsuchiya, and M. Sano, Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial, Clinical Cancer Research, vol.11, issue.11, pp.4160-4167, 2005.
DOI : 10.1158/1078-0432.CCR-05-0120

J. Yu, G. Liu, H. Ying, W. Yong, and K. Black, Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma, Cancer Research, vol.64, issue.14, pp.4973-4979, 2004.
DOI : 10.1158/0008-5472.CAN-03-3505

J. Simons, B. Mikhak, J. Chang, A. Demarzo, and M. Carducci, Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer, Cancer Res, vol.59, pp.5160-5168, 1999.

A. Palucka, H. Ueno, J. Connolly, F. Kerneis-norvell, and J. Blanck, Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity, Journal of Immunotherapy, vol.29, issue.5, pp.545-557, 2006.
DOI : 10.1097/01.cji.0000211309.90621.8b

E. Neidhardt-berard, F. Berard, J. Banchereau, and A. Palucka, Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes, Breast Cancer Research, vol.50, issue.4, pp.322-330, 2004.
DOI : 10.1002/jcb.240500403

S. Koido, N. Nikrui, M. Ohana, J. Xia, and Y. Tanaka, Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use, Gynecologic Oncology, vol.99, issue.2, pp.462-471, 2005.
DOI : 10.1016/j.ygyno.2005.07.019

J. Geiger, R. Hutchinson, L. Hohenkirk, E. Mckenna, and G. Yanik, Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression, Cancer Res, vol.61, pp.8513-8519, 2001.

H. Saito, D. Frleta, P. Dubsky, and A. Palucka, Dendritic Cell???Based Vaccination Against Cancer, Hematology/Oncology Clinics of North America, vol.20, issue.3, pp.689-710, 2006.
DOI : 10.1016/j.hoc.2006.02.011

M. Albert, Opinion: Death-defying immunity: do apoptotic cells influence antigen processing and presentation?, Nature Reviews Immunology, vol.104, issue.3, pp.223-231, 2004.
DOI : 10.1038/nri11308

URL : https://hal.archives-ouvertes.fr/pasteur-01402360

D. Orange, M. Jegathesan, N. Blachere, M. Frank, and H. Scher, Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy, Prostate Cancer and Prostatic Diseases, vol.7, issue.1, pp.63-72, 2004.
DOI : 10.1038/sj.pcan.4500694

URL : https://hal.archives-ouvertes.fr/pasteur-01402399

T. Putz, R. Ramoner, H. Gander, A. Rahm, and G. Bartsch, Monitoring of CD4+ and CD8+ T-Cell Responses After Dendritic Cell-Based Immunotherapy Using CFSE Dye Dilution Analysis, Journal of Clinical Immunology, vol.276, issue.5, pp.653-663, 2004.
DOI : 10.1007/s10875-004-6237-2

J. Banchereau, A. Palucka, M. Dhodapkar, S. Burkeholder, and N. Taquet, Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine, Cancer Res, vol.61, pp.6451-6458, 2001.

L. Fong, D. Brockstedt, C. Benike, L. Wu, and E. Engleman, Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients, The Journal of Immunology, vol.166, issue.6, pp.4254-4259, 2001.
DOI : 10.4049/jimmunol.166.6.4254

S. Raychaudhuri and K. Rock, Fully mobilizing host defense: building better vaccines, Nat Biotechnol, vol.16, pp.1025-1031, 1998.

A. Palucka, J. Connolly, H. Ueno, J. Kohl, and S. Paczesny, Spontaneous Proliferation and Type 2 Cytokine Secretion by CD4+T Cells in Patients with Metastatic Melanoma Vaccinated with Antigen-Pulsed Dendritic Cells, Journal of Clinical Immunology, vol.16, issue.3, pp.288-295, 2005.
DOI : 10.1007/s10875-005-4089-z

J. Bui and R. Schreiber, Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?, Current Opinion in Immunology, vol.19, issue.2, pp.203-208, 2007.
DOI : 10.1016/j.coi.2007.02.001

X. Zang and J. Allison, The B7 Family and Cancer Therapy: Costimulation and Coinhibition, Clinical Cancer Research, vol.13, issue.18, pp.5271-5279, 2007.
DOI : 10.1158/1078-0432.CCR-07-1030

L. Fong, S. Kwek, O. Brien, S. Kavanagh, B. Mcneel et al., Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF, Cancer Research, vol.69, issue.2, pp.609-615, 2009.
DOI : 10.1158/0008-5472.CAN-08-3529

K. Peggs, S. Quezada, A. Korman, and J. Allison, Principles and use of anti-CTLA4 antibody in human cancer immunotherapy, Current Opinion in Immunology, vol.18, issue.2, pp.206-213, 2006.
DOI : 10.1016/j.coi.2006.01.011

F. Sallusto and A. Lanzavecchia, Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha, Journal of Experimental Medicine, vol.179, issue.4, pp.1109-1118, 1994.
DOI : 10.1084/jem.179.4.1109

C. Rieser, G. Bock, H. Klocker, G. Bartsch, and M. Thurnher, Prostaglandin E2 and Tumor Necrosis Factor ?? Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production, Journal of Experimental Medicine, vol.183, issue.4, pp.1603-1608, 1997.
DOI : 10.1084/jem.183.4.1447